Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,158 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07183878Recruiting
Venetoclax with BUCY conditioning for high-risk AML or MDS transplant
This trial tests whether adding venetoclax (a pill that targets cancer cells) to the standard chemotherapy regimen before a stem cell transplant improves outcomes for people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). It is for patients aged 12–60 whose cancer has specific high-risk features and who have a matched donor.
Hangzhou, ZhejiangAges 12–60 - NCT04404400RecruitingPhase 3
Hydrocortisone and fludrocortisone for critical illness hormone shortage
This Phase 3 trial tests whether giving hydrocortisone plus fludrocortisone to critically ill ICU patients with suspected “corticosteroid insufficiency” can improve outcomes without relying on steroids already being used. It may help patients whose bodies aren’t making enough stress hormones during severe illness.
GarchesAges 18 years+ - NCT06938464Recruiting
Probiotics to prevent gestational diabetes in high-risk women
This study tests whether taking probiotics (friendly bacteria) during early pregnancy can help prevent gestational diabetes in women who are at higher risk for it.
Hangzhou, ZhejiangAges 18–50 - NCT05201404RecruitingPhase 3
Namodenoson for advanced liver cancer with moderate cirrhosis
This Phase 3 trial studies whether namodenoson can slow or control advanced hepatocellular carcinoma (liver cancer) in people whose cirrhosis is in a specific middle range. It may help if standard treatments have not worked or the cancer has spread and is not expected to be cured.
Dallas, TexasAges 18 years+ - NCT07183748RecruitingPhase 2
Psilocybin microdosing plus therapy for hard-to-treat depression
This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.
BeershebaAges 18–65 - NCT06939582RecruitingPhase 1/Phase 2
Hydroxychloroquine for radiation mouth sores
This trial tests if hydroxychloroquine tablets can prevent or reduce mouth sores caused by radiation therapy for head and neck cancer. If you are about to start radiation for head and neck cancer and have not had radiation before, this study might help manage painful mouth sores.
Chengdu, SichuanAges 18–80 - NCT06575868Recruiting
Can myo-inositol prevent gestational diabetes in pregnancy?
This study tests whether a supplement called myo-inositol (a natural sugar-like substance) can help prevent gestational diabetes in pregnant women with obesity. If you join, you will wear a continuous glucose monitor to track your blood sugar levels and might take the supplement or a placebo.
Boston, MassachusettsAges 18–45 - NCT06948357RecruitingPhase 2
Eye drops for presbyopia in Chinese adults
This trial tests two eye drops, BRIMOCHOL PF and CARBACHOL PF, to see if they improve near vision in people with presbyopia (age-related difficulty seeing up close). The study is for Chinese adults aged 45-75 who have trouble reading even with glasses or contacts.
Wenzhou, ZhejiangAges 45–75 - NCT07182890RecruitingPhase 4
Probiotic for anxiety and depression in functional dyspepsia
This trial tests whether a probiotic called Clostridium Butyricum can help reduce anxiety and depression in people with functional dyspepsia (a type of stomach discomfort without a clear cause). If you have mild to moderate anxiety or depression along with your stomach symptoms, this study may offer a potential new treatment option.
Xi’an, ShanxiAges 18–80 - NCT07176546RecruitingPhase 2/Phase 3
Testing TAVNEOS for ear, nose, and throat symptoms in GPA
This trial tests a new drug called TAVNEOS (avacopan) for people with Granulomatosis with Polyangiitis (GPA) whose symptoms affect the ears, nose, or throat. The goal is to see if this drug can reduce inflammation and improve these symptoms better than current treatments.
Edison, New JerseyAges 18 years+ - NCT07183384RecruitingPhase 1/Phase 2
Exosome therapy for blood vessel health after preeclampsia
This study tests whether exosomes from mesenchymal stem cells can help repair the blood vessels after preeclampsia. If you delivered within the last two weeks and had preeclampsia, you may qualify to take part.
Bandung, West JavaAges 18–50 - NCT07174947RecruitingPhase 2
Fluoxetine plus immunotherapy for advanced liver cancer with depression
This study tests whether adding the antidepressant fluoxetine (Prozac) to standard immunotherapy can help treat advanced liver or bile duct cancer in people who also have depression or anxiety. You must not have received any prior cancer treatment and be ready to start immunotherapy as your first therapy.
Wenzhou, ZhejiangAges 18–80 - NCT07174687RecruitingPhase 2
SGLT2 inhibitor for geographic atrophy
This study tests an SGLT2 inhibitor (dapagliflozin) as a possible treatment for geographic atrophy, a progressive form of dry age-related macular degeneration that causes vision loss. It is for people who meet specific eye and health criteria.
St Louis, MissouriAges 50 years+ - NCT07182500RecruitingPhase 2
Can probiotics protect your gut while traveling?
This trial tests whether taking a probiotic supplement can help keep your gut bacteria healthy during a short trip abroad. It's a good fit if you are generally healthy and planning a vacation or business trip under a week.
Huangpu, Shanghai MunicipalityAges 18–65 - NCT07183215Enrolling by invitationPhase 2/Phase 3
Turmeric capsules for knee osteoarthritis inflammation
This study tests whether a turmeric capsule (curcumin) can reduce inflammation in people with knee osteoarthritis. It may help with pain and swelling without the side effects of standard anti-inflammatory drugs.
YogyakartaAges 60 years+ - NCT07176533Recruiting
Nerve block for pain after tonsil surgery in kids
This study tests a nerve block (a numbing injection near the cheekbone) to reduce pain after tonsil surgery in children with sleep apnea. It might help them have less pain and recover more comfortably.
London, OntarioAges 3–9 - NCT07181486RecruitingPhase 1
Safety study of a vaginal gel for healthy women
This trial tests a gel placed in the vagina to see if it is safe. Healthy women with regular periods who have a steady partner may join.
San Francisco, CaliforniaAges 18–45 - NCT07181135Enrolling by invitationPhase 3
Finerenone for kidney disease without certain blood pressure drugs
This trial tests if finerenone can protect kidneys in people with chronic kidney disease who are not taking common blood pressure medications called ACE inhibitors, ARBs, or renin inhibitors. It may help slow kidney damage.
BarcelonaAges 18 years+ - NCT07180277RecruitingPhase 4
Steroid treatment for moderate to severe brain injury
This trial tests a steroid medicine called methylprednisolone to see if it can help people who have had a moderate to severe brain injury. It aims to reduce swelling in the brain and possibly improve recovery.
Suzhou, JiangsuAges 18–65 - NCT07178262RecruitingPhase 4
Nerve block to reduce pain medicine after hysterectomy
This study tests whether a nerve block (an injection near the spine) can help reduce the amount of strong pain medicine you need after a hysterectomy. The goal is to see if it leads to fewer side effects and a smoother recovery.
Islamabad, FederalAges 16–80 - NCT07177183Recruiting
Low creatinine as a sign of longer breathing tube use
This study looks at whether low blood creatinine levels can help predict which patients will need a breathing machine for a long time or have trouble coming off it. If you are under 18 and in a post-ICU care unit, you may be able to join.
BrnoAges 18 years+ - NCT07177911RecruitingPhase 1
Study of CC312 for moderate to severe lupus
This trial tests a new medicine called CC312 for people with moderate to severe lupus (SLE) that hasn't improved with standard treatments. The goal is to see if it is safe and can help control the disease.
Chengdu, SichuanAges 18–65 - NCT07179640RecruitingPhase 1/Phase 2
Testing ALE1 for hypophosphatasia in healthy people and patients
This trial tests a new medicine called ALE1 for hypophosphatasia (HPP), a rare bone condition. It first checks safety in healthy volunteers, then tests if the medicine helps people with HPP.
WürzburgAges 18–50 - NCT07177339RecruitingPhase 3
Testing depemokimab for COPD with type 2 inflammation
This study tests an early treatment called depemokimab for people with moderate to severe COPD who have a type of inflammation linked to high eosinophils. It aims to reduce flare-ups and improve breathing.
Newport Beach, CaliforniaAges 40–75
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,158 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.